Before baseline screening | Baseline | Visit 1 treatment phase | Visit 2 treatment phase | Visit 3 treatment phase | Visit 4 treatment phase | Visit 5 follow-up phase | |
---|---|---|---|---|---|---|---|
(before chemo) | Before 2nd chemo | Before 3rd chemo | Before 4th chemo | Before 5th chemo | 1 month after chemo | ||
Patients | |||||||
Inclusion and exclusion criteria | × | ||||||
Informed consent | × | ||||||
Demographics | × | ||||||
Medical characteristics | × | × | × | × | × | × | × |
Randomization and allocation concealment | × | ||||||
Primary outcomes | |||||||
Grading of hair loss | × | × | × | × | × | × | |
Objective indices (hair quality and hair follicles) | × | × | × | × | × | × | |
Secondary outcomes | |||||||
Facial color and thumbnail color | × | × | × | × | × | × | |
Grading of thumbnail ridging | × | × | × | × | × | × | |
Quality of life and fatigue | × | × | × | × | × | × | |
Routine blood test | × | × | × | × | × | × | |
Liver function (ALT, AST, total protein, and Alba) | × | × | × | × | × | × | |
Renal function (Cr, UA and BUN) | × | × | × | × | × | × | |
Kidney deficiency (IgM, C3、CD4 +, CD8 + Mg2+, Cu2+, Zn2+, Fe3+) | × | × | × | ||||
Adverse events | × | × | × | × | × | ||
Patients’ diary records | Every day during the study |